MEAGEN HERONEMUS: Open Payments
NPI 1497371934 · CORSICANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 36 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $479 · 2025 $710
Food & beverage: $573Education: $137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $155 |
| AstraZeneca Pharmaceuticals LP | 5 | $140 |
| Astellas Pharma US Inc | 2 | $137 |
| Dexcom, Inc. | 6 | $100 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Novo Nordisk Inc | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Corcept Therapeutics | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| CeQur Corporation | 1 | $15 |
Products named: VRAYLAR, Dexcom G6 Transmitter, FARXIGA, Auvelity, AIRSUPRA, Wegovy, REXULTI, BREZTRI.
Industry payments across TX — which companies pay providers there.
